These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35985928)

  • 1. Epidemiology of pediatric parapneumonic pleural effusion during 13-valent pneumococcal conjugate vaccine implementation.
    Moral L; Toral T; Marco N; Clavijo A; Canals F; Forniés MJ; González MC; Moral J; Márquez M; Lucas R; Caballero M; Huertas AM; García-Avilés B; Belda M
    Enferm Infecc Microbiol Clin (Engl Ed); 2023; 41(7):414-419. PubMed ID: 35985928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in Germany.
    Goettler D; Streng A; Kemmling D; Schoen C; von Kries R; Rose MA; van der Linden M; Liese JG
    Vaccine; 2020 Jan; 38(3):570-577. PubMed ID: 31735502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions/empyema in Germany, 2010-2017: a nationwide surveillance study.
    Liese JG; Schoen C; van der Linden M; Lehmann L; Goettler D; Keller S; Maier A; Segerer F; Rose MA; Streng A
    Clin Microbiol Infect; 2019 Jul; 25(7):857-864. PubMed ID: 30395932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case report of parapneumonic pleural effusion caused by Streptococcus pneumoniae serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine.
    Diawara I; Zerouali K; Elmdaghri N; Abid A
    BMC Pediatr; 2017 Apr; 17(1):114. PubMed ID: 28449653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13-valent pneumococcal conjugate vaccine era.
    Díaz-Conradi A; Hernández S; García-García JJ; Muñoz-Almagro C; Moraga-Llop F; Ciruela P; Izquierdo C; Campins M; de Sevilla MF; González-Peris S; Uriona S; Martínez-Osorio J; Solé-Ribalta A; Codina G; Esteva C; Planes AM; Soldevila N; Salleras L; Domínguez A
    Pediatr Pulmonol; 2019 May; 54(5):517-524. PubMed ID: 30784235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence trends of parapneumonic pleural effusions/empyema in children 2009 to 2018 from health insurance data: Only temporal reduction after the introduction of PCV13.
    Sorg AL; Obermeier V; Liese JG; von Kries R
    Vaccine; 2021 Jun; 39(26):3516-3519. PubMed ID: 34006409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine.
    Syrogiannopoulos GA; Michoula AN; Tsimitselis G; Vassiou K; Chryssanthopoulou DC; Grivea IN
    Infect Dis (Lond); 2016 Oct; 48(10):749-53. PubMed ID: 27320108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation.
    Madhi F; Levy C; Morin L; Minodier P; Dubos F; Zenkhri F; Dommergues MA; Mezgueldi E; Levieux K; ; Béchet S; Varon E; Cohen R;
    J Pediatric Infect Dis Soc; 2019 Nov; 8(5):474-477. PubMed ID: 30407519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parapneumonic effusions related to
    Hyams C; Arnold DT; Heath R; Amin-Chowdhury Z; Hettle D; Ruffino G; North P; Grimes C; Fry NK; Williams P; Challen R; Danon L; Williams OM; Ladhani S; Finn A; Maskell N
    BMJ Open Respir Res; 2023 May; 10(1):. PubMed ID: 37147024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etiology of parapneumonic effusion and pleural empyema in children. The role of conventional and molecular microbiological tests.
    Krenke K; Sadowy E; Podsiadły E; Hryniewicz W; Demkow U; Kulus M
    Respir Med; 2016 Jul; 116():28-33. PubMed ID: 27296817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parapneumonic pleural effusion incidence in a French region before and during the antipneumococcal vaccine era].
    Masson A; Ménetrey C; Garnier F; Bahans C; Fargeot A; Layadi M; Soulier JL; Guigonis V
    Arch Pediatr; 2011 Aug; 18(8):846-9. PubMed ID: 21664805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is the incidence of parapneumonic pleural effusion increasing?].
    Bueno Campaña M; Agúndez Reigosa B; Jimeno Ruiz S; Echávarri Olavarría F; Martínez Granero MA
    An Pediatr (Barc); 2008 Feb; 68(2):92-8. PubMed ID: 18341872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct Streptococcus pneumoniae real-time PCR serotyping from pediatric parapneumonic effusions.
    Slinger R; Hyde L; Moldovan I; Chan F; Pernica JM
    BMC Pediatr; 2014 Jul; 14():189. PubMed ID: 25060939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010-2015.
    Silva-Costa C; Brito MJ; Pinho MD; Friães A; Aguiar SI; Ramirez M; Melo-Cristino J; ;
    Emerg Infect Dis; 2018 Jul; 24(7):1307-1314. PubMed ID: 29912700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of pediatric parapneumonic effusion/empyema in New Zealand.
    Rix-Trott K; Byrnes CA; Gilchrist CA; Matsas R; Walls T; Voss L; Mahon C; Dickson NP; Reed P; Best EJ
    Pediatr Pulmonol; 2021 Sep; 56(9):2949-2957. PubMed ID: 34232567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal conjugate vaccines decrease community-acquired alveolar pneumonia with and without pleural effusion in children <60 months in Southern Israel, 2002-2016.
    Triadou D; Givon-Lavi N; Greenberg D; Ben-Shimol S
    Infect Dis (Lond); 2020 Mar; 52(3):186-195. PubMed ID: 31774020
    [No Abstract]   [Full Text] [Related]  

  • 17. Significant impact of pneumococcal conjugate vaccination on pediatric parapneumonic effusion: Italy 2006-2018.
    Azzari C; Serranti D; Nieddu F; Moriondo M; Casini A; Lodi L; de Benedictis FM; De Vitis E; Cavone F; Cortimiglia M; Indolfi G; Lombardi E; Carloni I; Cutrera R; Lucenteforte E; Resti M; Ricci S
    Vaccine; 2019 May; 37(20):2704-2711. PubMed ID: 30981627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric parapneumonic effusion before and after national pneumococcal vaccination programs in Taiwan.
    Sim JY; Chang LY; Chang TH; Chen JM; Lee PI; Huang LM; Lu CY
    J Formos Med Assoc; 2020 Nov; 119(11):1608-1618. PubMed ID: 32747171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology.
    Fletcher MA; Schmitt HJ; Syrochkina M; Sylvester G
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):879-910. PubMed ID: 24563274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.
    Byington CL; Korgenski K; Daly J; Ampofo K; Pavia A; Mason EO
    Pediatr Infect Dis J; 2006 Mar; 25(3):250-4. PubMed ID: 16511389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.